nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0302	0.0302	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0259	0.0259	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0254	0.0254	CcSEcCtD
Oritavancin—Oedema peripheral—Entecavir—hepatitis B	0.0239	0.0239	CcSEcCtD
Oritavancin—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0233	0.0233	CcSEcCtD
Oritavancin—Immune system disorder—Entecavir—hepatitis B	0.0219	0.0219	CcSEcCtD
Oritavancin—Wheezing—Lamivudine—hepatitis B	0.0217	0.0217	CcSEcCtD
Oritavancin—Malnutrition—Entecavir—hepatitis B	0.0211	0.0211	CcSEcCtD
Oritavancin—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.0206	0.0206	CcSEcCtD
Oritavancin—Connective tissue disorder—Telbivudine—hepatitis B	0.0196	0.0196	CcSEcCtD
Oritavancin—Anaemia—Adefovir Dipivoxil—hepatitis B	0.019	0.019	CcSEcCtD
Oritavancin—Mediastinal disorder—Telbivudine—hepatitis B	0.018	0.018	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.0179	0.0179	CcSEcCtD
Oritavancin—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0175	0.0175	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0174	0.0174	CcSEcCtD
Oritavancin—Malnutrition—Telbivudine—hepatitis B	0.0173	0.0173	CcSEcCtD
Oritavancin—Infection—Entecavir—hepatitis B	0.0171	0.0171	CcSEcCtD
Oritavancin—Nervous system disorder—Entecavir—hepatitis B	0.0169	0.0169	CcSEcCtD
Oritavancin—Skin disorder—Entecavir—hepatitis B	0.0167	0.0167	CcSEcCtD
Oritavancin—Hypoglycaemia—Lamivudine—hepatitis B	0.0166	0.0166	CcSEcCtD
Oritavancin—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0165	0.0165	CcSEcCtD
Oritavancin—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.0163	0.0163	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.0153	0.0153	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Entecavir—hepatitis B	0.0149	0.0149	CcSEcCtD
Oritavancin—Myalgia—Telbivudine—hepatitis B	0.0148	0.0148	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0147	0.0147	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.0146	0.0146	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.0145	0.0145	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.0143	0.0143	CcSEcCtD
Oritavancin—Nervous system disorder—Telbivudine—hepatitis B	0.0139	0.0139	CcSEcCtD
Oritavancin—Skin disorder—Telbivudine—hepatitis B	0.0138	0.0138	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.0129	0.0129	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0122	0.0122	CcSEcCtD
Oritavancin—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0119	0.0119	CcSEcCtD
Oritavancin—Diarrhoea—Entecavir—hepatitis B	0.0118	0.0118	CcSEcCtD
Oritavancin—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.0115	0.0115	CcSEcCtD
Oritavancin—Dizziness—Entecavir—hepatitis B	0.0114	0.0114	CcSEcCtD
Oritavancin—Connective tissue disorder—Lamivudine—hepatitis B	0.011	0.011	CcSEcCtD
Oritavancin—Vomiting—Entecavir—hepatitis B	0.011	0.011	CcSEcCtD
Oritavancin—Rash—Entecavir—hepatitis B	0.0109	0.0109	CcSEcCtD
Oritavancin—Dermatitis—Entecavir—hepatitis B	0.0109	0.0109	CcSEcCtD
Oritavancin—Headache—Entecavir—hepatitis B	0.0108	0.0108	CcSEcCtD
Oritavancin—Vomiting—Adefovir Dipivoxil—hepatitis B	0.0107	0.0107	CcSEcCtD
Oritavancin—Erythema multiforme—Lamivudine—hepatitis B	0.0106	0.0106	CcSEcCtD
Oritavancin—Rash—Adefovir Dipivoxil—hepatitis B	0.0106	0.0106	CcSEcCtD
Oritavancin—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.0106	0.0106	CcSEcCtD
Oritavancin—Headache—Adefovir Dipivoxil—hepatitis B	0.0105	0.0105	CcSEcCtD
Oritavancin—Nausea—Entecavir—hepatitis B	0.0102	0.0102	CcSEcCtD
Oritavancin—Immune system disorder—Lamivudine—hepatitis B	0.0101	0.0101	CcSEcCtD
Oritavancin—Mediastinal disorder—Lamivudine—hepatitis B	0.0101	0.0101	CcSEcCtD
Oritavancin—Pruritus—Telbivudine—hepatitis B	0.01	0.01	CcSEcCtD
Oritavancin—Nausea—Adefovir Dipivoxil—hepatitis B	0.00999	0.00999	CcSEcCtD
Oritavancin—Malnutrition—Lamivudine—hepatitis B	0.00978	0.00978	CcSEcCtD
Oritavancin—Diarrhoea—Telbivudine—hepatitis B	0.00969	0.00969	CcSEcCtD
Oritavancin—Dizziness—Telbivudine—hepatitis B	0.00936	0.00936	CcSEcCtD
Oritavancin—Anaemia—Lamivudine—hepatitis B	0.00904	0.00904	CcSEcCtD
Oritavancin—Vomiting—Telbivudine—hepatitis B	0.009	0.009	CcSEcCtD
Oritavancin—Angioedema—Lamivudine—hepatitis B	0.00893	0.00893	CcSEcCtD
Oritavancin—Rash—Telbivudine—hepatitis B	0.00893	0.00893	CcSEcCtD
Oritavancin—Dermatitis—Telbivudine—hepatitis B	0.00892	0.00892	CcSEcCtD
Oritavancin—Headache—Telbivudine—hepatitis B	0.00887	0.00887	CcSEcCtD
Oritavancin—Nausea—Telbivudine—hepatitis B	0.00841	0.00841	CcSEcCtD
Oritavancin—Myalgia—Lamivudine—hepatitis B	0.00832	0.00832	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00827	0.00827	CcSEcCtD
Oritavancin—Infection—Lamivudine—hepatitis B	0.00793	0.00793	CcSEcCtD
Oritavancin—Nervous system disorder—Lamivudine—hepatitis B	0.00782	0.00782	CcSEcCtD
Oritavancin—Skin disorder—Lamivudine—hepatitis B	0.00775	0.00775	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00727	0.00727	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00689	0.00689	CcSEcCtD
Oritavancin—Urticaria—Lamivudine—hepatitis B	0.00634	0.00634	CcSEcCtD
Oritavancin—Hypersensitivity—Lamivudine—hepatitis B	0.00588	0.00588	CcSEcCtD
Oritavancin—Pruritus—Lamivudine—hepatitis B	0.00564	0.00564	CcSEcCtD
Oritavancin—Diarrhoea—Lamivudine—hepatitis B	0.00546	0.00546	CcSEcCtD
Oritavancin—Dizziness—Lamivudine—hepatitis B	0.00528	0.00528	CcSEcCtD
Oritavancin—Vomiting—Lamivudine—hepatitis B	0.00507	0.00507	CcSEcCtD
Oritavancin—Rash—Lamivudine—hepatitis B	0.00503	0.00503	CcSEcCtD
Oritavancin—Dermatitis—Lamivudine—hepatitis B	0.00503	0.00503	CcSEcCtD
Oritavancin—Headache—Lamivudine—hepatitis B	0.005	0.005	CcSEcCtD
Oritavancin—Nausea—Lamivudine—hepatitis B	0.00474	0.00474	CcSEcCtD
